Regenxbio (RGNX) Non-Current Assets (2014 - 2026)
Regenxbio (RGNX) posted Non-Current Assets of $150.46 million for Q2 2026, down 27.4% from $207.28 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio's Non-Current Assets came in at $171.75 million, down 8.6% from FY2024.
- Annual Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- In prior years, Regenxbio's Non-Current Assets was $187.99 million in FY2024 (-21.3%), $239 million in FY2023 (-42.7%), $417.29 million in FY2022 (-29.9%) and $595.08 million in FY2021 (+236.3%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q2 2020.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2021, with growth of 236.3%; the weakest was Q4 2023, with a decline of 42.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Regenxbio | 404.61 Mn | -528.48 Mn | - | 150.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 150.46 Mn |
| Dec 31, 2025 | 171.75 Mn |
| Sep 30, 2025 | 193.24 Mn |
| Jun 30, 2025 | 207.28 Mn |
| Mar 31, 2025 | 177.69 Mn |
| Dec 31, 2024 | 187.99 Mn |
| Sep 30, 2024 | 205.72 Mn |
| Jun 30, 2024 | 222.70 Mn |
| Mar 31, 2024 | 233.80 Mn |
| Dec 31, 2023 | 239.00 Mn |
| Sep 30, 2023 | 267.95 Mn |
| Jun 30, 2023 | 303.65 Mn |
| Mar 31, 2023 | 358.63 Mn |
| Dec 31, 2022 | 417.29 Mn |
| Sep 30, 2022 | 447.15 Mn |
| Jun 30, 2022 | 488.02 Mn |
| Mar 31, 2022 | 578.49 Mn |
| Dec 31, 2021 | 595.08 Mn |
| Sep 30, 2021 | 390.23 Mn |
| Jun 30, 2021 | 399.02 Mn |
API Access
Regenxbio Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();